Lyell Immunopharma (LYEL) EBT Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 441.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,297.00
10 Lyell Immunopharma 373.31 Mn 373.31 Mn - -201.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -201.40 Mn
Dec 31, 2025 -208.28 Mn
Sep 30, 2025 191.30 Mn
Jun 30, 2025 -54.82 Mn
Mar 31, 2025 -75.20 Mn
Dec 31, 2024 -178.22 Mn
Sep 30, 2024 -12.92 Mn
Jun 30, 2024 -34.50 Mn
Mar 31, 2024 -162.29 Mn
Dec 31, 2023 -40.16 Mn
Sep 30, 2023 -20.64 Mn
Jun 30, 2023 -22.14 Mn